Your browser doesn't support javascript.
loading
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study.
Basak, Edwin A; Vermeer, Niels S; de Joode, Karlijn; Hurkmans, Daan P; Velthuis, Dorian E M; Oomen-de Hoop, Esther; Schreurs, Marco W J; Bins, Sander; Koolen, Stijn L W; Debets, Reno; van der Veldt, Astrid A M; Aerts, Joachim G J V; Joosse, Arjen; Mathijssen, Ron H J.
Afiliação
  • Basak EA; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: e.basak@erasmusmc.nl.
  • Vermeer NS; Dept. of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • de Joode K; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Hurkmans DP; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Velthuis DEM; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Oomen-de Hoop E; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Schreurs MWJ; Dept. of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Bins S; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Koolen SLW; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Dept. of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Debets R; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • van der Veldt AAM; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Dept. of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Aerts JGJV; Dept. of Pulmonology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Joosse A; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Mathijssen RHJ; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Eur J Cancer ; 174: 113-120, 2022 10.
Article em En | MEDLINE | ID: mdl-35988409
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Melanoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Melanoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article